Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03291353
Title Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Michael Boyiadzis
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.